Corpay, Inc.
CPAYLast close · Oct 16, 2026399.84−6.36 (−1.57%)
Market cap$26.3B
8 firms' latest targets, last 90 days: median $465.00 ($415.00–$536.00), 16% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-09-02 | Scotiabank | $536.00 | — | +34% |
| 2026-08-31 | RBC Capital | $438.00 | ▲ 4% | +10% |
| 2026-08-25 | Wolfe Research | $530.00 | ▲ 12% | +33% |
| 2026-08-10 | Cantor Fitzgerald | $480.00 | ▲ 25% | +20% |
| 2026-08-07 | Morgan Stanley | $455.00 | ▲ 10% | +14% |
| 2026-08-06 | Baird | $475.00 | — | +19% |
| 2026-08-06 | UBS | $415.00 | ▲ 9% | +4% |
| 2026-08-06 | Raymond James | $442.00 | ▲ 22% | +11% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2021reported | $2.8B | +19% | $9.99 | +23% | est. $2.8B+1% | est. $13.06 | 6 |
| 2022reported | $3.4B | +21% | $12.42 | +24% | est. $3.4B+0% | est. $15.98 | 5 |
| 2023reported | $3.8B | +10% | $13.20 | +6% | est. $3.8B-1% | est. $16.96 | 10 |
| 2024reported | $4.0B | +6% | $13.97 | +6% | est. $4.0B+0% | est. $18.98 | 12 |
| 2025reported | $4.5B | +14% | $15.03 | +8% | est. $4.5B+0% | est. $21.28 | 10 |
| 2026 | $5.3B | +17% | $27.41 | +29% | $5.3B–$5.4B | $27.34–$27.67 | 12 |
| 2027 | $5.8B | +9% | $31.47 | +15% | $5.6B–$5.9B | $29.62–$32.63 | 12 |
| 2028 | $6.3B | +9% | $36.87 | +17% | $6.1B–$6.4B | $33.72–$39.33 | 8 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.